Award
Delivery Order #SPE2DR26FBUS0
AmerisourceBergen Delivery Order for Hydroxyzine Tablets under Long-Term Pharmaceutical IDV
Buyer
Defense Logistics Agency
Award Amount
$83.34
Ceiling
$83.34
Awarded
March 03, 2026
Period of Performance
Mar 03, 2026 – Mar 04, 2026
Identifier
SPE2DR26FBUS0
NAICS
424210
This award represents a delivery order contract issued to AmerisourceBergen Drug Corp, a leading healthcare solutions and pharmaceutical distribution company. The order involves the procurement of Hydroxyzine HCL 25 MG Tablets, a pharmaceutical product essential for medical treatment. This specific delivery order is a subordinate procurement under a substantial Indefinite Delivery Vehicle (IDV) contract focused on pharmaceutical distribution services. The contract underscores the importance of dependable access to critical medications for healthcare providers, supporting public health infrastructure. The scope includes the timely delivery of the specified pharmaceutical product to the designated location in Conshohocken, Pennsylvania, within a short performance window. The contract was awarded as a delivery order likely under the existing competitive framework established by the IDV, ensuring continuity and efficiency in supply chain operations. The performance period is brief, reflecting the prompt fulfillment of a targeted pharmaceutical need. This delivery order builds upon an ongoing, long-term partnership established by the parent IDV contract, facilitating streamlined procurement and distribution processes critical to the agency's pharmaceutical needs.
Description
4571017499!HYDROXYZINE HCL 25 MG TABLET 500S